Nikolas Tsavaris
Overview
Explore the profile of Nikolas Tsavaris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Polyzos K, Karadima M, Kosma A, Lazaris A, Kavantzas N, Tsavaris N
In Vivo
. 2018 Dec;
33(1):245-249.
PMID: 30587631
Background/aim: The aim of the present study was the evaluation of the influence of cancer stem cells and other parameters in stage IV colorectal cancer patients. Materials And Methods: One...
2.
Koufos N, Syrios J, Michailidou D, Xynos I, Lazaris A, Kavantzas N, et al.
Mol Clin Oncol
. 2016 Oct;
5(4):440-446.
PMID: 27699040
The expression of various angiogenic factors was assessed in tumour samples of patients with stage III non-small-cell lung cancer (NSCLC) and further evaluated in terms of response to induction paclitaxel-ifosfamide-cisplatin...
3.
Xynos I, Kavantzas N, Tsaousi S, Zacharakis M, Agrogiannis G, Kosmas C, et al.
ISRN Gastroenterol
. 2013 Jul;
2013:490578.
PMID: 23840958
Objective. To evaluate the prognostic significance of microscopically assessed DNA ploidy and other clinical and laboratory parameters in stage IV colorectal cancer (CRC). Methods. 541 patients with histologically proven stage...
4.
Syrios J, Kechagias G, Agrogiannis G, Xynos I, Kavantzas N, Lazaris A, et al.
Anticancer Res
. 2013 Mar;
33(3):1209-14.
PMID: 23482804
Background: Metastatic gastric adenocarcinoma confers a dismal prognosis. Several prognostic factors are needed to distinguish patients that will benefit from chemotherapy. In this setting, the prognostic impact of DNA ploidy...
5.
Xynos I, Karadima M, Voutsas I, Amptoulach S, Skopelitis E, Kosmas C, et al.
Oncology
. 2013 Mar;
84(5):273-83.
PMID: 23445638
Objective: To identify changes in peripheral immune responses in patients with metastatic colorectal cancer (mCRC) treated with irinotecan/5-fluorouracil/leucovorin (IFL) alone or in combination with cetuximab (C-IFL). Methods: Peripheral blood mononuclear...
6.
Polyzos A, Felekouras E, Karatzas T, Griniatsos J, Dimitroulis D, Polyzos K, et al.
Anticancer Res
. 2012 Sep;
32(9):4151-6.
PMID: 22993377
The combination of docetaxel, cisplatin and fluorouracil is considered to be one of the reference regimens for advanced gastric cancer, but due to its major myelotoxicity, its use in clinical...
7.
Syrios J, Sougioultzis S, Xynos I, Kavantzas N, Kosmas C, Agrogiannis G, et al.
BMC Cancer
. 2012 Aug;
12:264.
PMID: 22892134
Background: Palliative surgery followed by postoperative chemotherapy is a challenging approach in the treatment of stage IV gastric cancer yet patients must be carefully selected on the basis of likely...
8.
Zacharakis M, Xynos I, Lazaris A, Smaro T, Kosmas C, Dokou A, et al.
Anticancer Res
. 2010 Mar;
30(2):653-60.
PMID: 20332485
Unlabelled: The aim of this study was to evaluate predictors of survival in stage IV metastatic colorectal cancer (CRC). Patients And Methods: A total of 541 patients with histologically proven...
9.
Tsavaris N, Kavantzas N, Tsigritis K, Xynos I, Papadoniou N, Lazaris A, et al.
BMC Cancer
. 2009 Aug;
9:264.
PMID: 19646258
Background: Most patients with ductal pancreatic adenocarcinoma are diagnosed with locally advanced (unresectable) or metastatic disease. The aim of this study was to evaluate the prognostic significance of DNA ploidy...
10.
Polyzos A, Gogas H, Markopoulos C, Tsavaris N, Papadopoulos O, Polyzos K, et al.
Anticancer Res
. 2009 Jul;
29(7):2851-6.
PMID: 19596973
There is no standard treatment for breast cancer patients whose tumors have been exposed both to anthracyclines and taxanes. Oxaliplatin shows synergism with 5-fluorouracil (5-FU) and capecitabine is an oral...